200 SUMMIT DRIVE, BURLINGTON, MA
Announces Leadership Transition to Accelerate Gene Synthesis Strategy and Multiomics Execution
Other Events
Exhibit 99.1
Reports First Quarter Results for Fiscal 2026, Ended December 31, 2025
Departure of Officer - Ephraim Starr Resigns from Azenta, Inc.
Shareholder votes
Material Contracts, Reg. FD
Annual Report to Security Holders
Q2
Q1
FY 2025
Notice of Late Filing for Annual Report
Q3
FY 2024
Registration Statement for Securities to be Offered to Employees
S-3ASR
Definitive Proxy Statement
Additional Proxy Materials
Statement of Changes in Beneficial Ownership
Schedule 13G - Ownership Report
Initial Statement of Beneficial Ownership
Amended Schedule 13G - Ownership Report
Definitive Revised Proxy Statement
Specialized Disclosure Report